BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23874588)

  • 1. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
    Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
    PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
    deVere White RW; Tsodikov A; Stapp EC; Soares SE; Fujii H; Hackman RM
    Nutr Cancer; 2010; 62(8):1036-43. PubMed ID: 21058191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specific role of isoflavones in reducing prostate cancer risk.
    Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
    Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
    Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.
    Kumar NB; Krischer JP; Allen K; Riccardi D; Besterman-Dahan K; Salup R; Kang L; Xu P; Pow-Sang J
    Nutr Cancer; 2007; 59(2):163-8. PubMed ID: 18001210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
    Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
    JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
    Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
    Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.
    Lazarevic B; Boezelijn G; Diep LM; Kvernrod K; Ogren O; Ramberg H; Moen A; Wessel N; Berg RE; Egge-Jacobsen W; Hammarstrom C; Svindland A; Kucuk O; Saatcioglu F; Taskèn KA; Karlsen SJ
    Nutr Cancer; 2011; 63(6):889-98. PubMed ID: 21714686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
    Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
    Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
    Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
    Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients.
    Yari Z; Tabibi H; Najafi I; Hedayati M; Movahedian M
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1382-1388. PubMed ID: 32513581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
    deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
    Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.
    Kumar NB; Kang L; Pow-Sang J; Xu P; Allen K; Riccardi D; Besterman-Dahan K; Krischer JP
    J Soc Integr Oncol; 2010; 8(1):3-13. PubMed ID: 20205984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.
    Adams KF; Chen C; Newton KM; Potter JD; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):644-8. PubMed ID: 15066931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
    Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen.
    Urban D; Irwin W; Kirk M; Markiewicz MA; Myers R; Smith M; Weiss H; Grizzle WE; Barnes S
    J Urol; 2001 Jan; 165(1):294-300. PubMed ID: 11125428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
    Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S
    Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
    Pendleton JM; Tan WW; Anai S; Chang M; Hou W; Shiverick KT; Rosser CJ
    BMC Cancer; 2008 May; 8():132. PubMed ID: 18471323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.